查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医疗植入物市场 - 2023-2030
市场调查报告书
商品编码
1348008

全球医疗植入物市场 - 2023-2030

Global Medical Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

医疗植入物被放置在身体内部或表面，以取代缺失的生物结构、支撑受损的生物结构并增强现有的生物结构。其他医疗植入物有助于输送药物、监测身体功能并为器官和组织提供支援。

医疗植入物可以永久或暂时放置。例如，支架或髋关节植入物是永久性的，但用于修復骨折的化疗端口或螺丝在不再需要时可以移除。植入物的表面由钛、硅树脂或磷灰石等生物医学材料製成。

此外，技术进步的不断进步、产品的推出和优惠的报销政策等重要的成长动力将推动未来的市场成长。 Orthopedic Implant Company、Auxein Medical、Medtronic Plc.、Stryker Corporation 等重要参与者都在市场上积极运作。

动力学

增加医疗植体的产品发布

医疗植入物用作义肢，旨在取代缺失的身体部位。大公司推出的产品有助于推动市场成长，这些有效的产品发布有助于将研究发现转化为新的治疗方法并改善数百万人的护理。

例如，2023 年 2 月，OSSIO, Inc. 推出了全新 OSSIO Fiber Compression Staple。 OSSIO Fiber 加压缝合钉采用 OSSIO Fiber 智慧骨再生技术製成。 OSSIO Fiber 透过在非永久植入物中结合无与伦比的机械强度和自然骨癒合，为永久金属硬体和传统可吸收和同种异体移植植入物的缺点提供了第一个可靠的解决方案。

此外，雅培实验室于 2022 年 12 月推出了名为 Navitor 的最新一代经导管主动脉瓣植入 (TAVI) 系统，为处于高或极高手术风险的严重主动脉瓣狭窄患者提供微创设备。因此，由于上述因素，预计市场在预测期内将会提振。

优惠报销政策助推医疗植入物市场

报销政策通常会考虑手术的复杂性、使用的植入物类型以及手术期间使用的相关医疗资源等因素。报销政策在医疗植入市场中发挥着至关重要的作用，因为它们决定了向医疗保健提供者提供的用于执行植入手术的承保范围和财务报销水平。

例如，2023 年 3 月，Inspire Medical Systems, Inc. 表示，已在比利时获得全国报销批准，其费率与世界其他国家一致。此次报销批准为在安特卫普大学医院 (UZA) 的指导下在比利时开设更多 Inspire 植入中心提供了一条途径，同时也扩大了医疗服务的覆盖范围。

此外，2022 年 11 月，Establishment Labs Holdings Inc. 宣布 Motiva Implants 和 Motiva Flora 组织扩张器已获得药品和医疗器材管理局 (PMDA) 批准在日本使用，这些产品还获得了乳房切除术后的报销日本国民保健系统下的重建。

与牙植体相关的併发症将阻碍市场的成长

植牙的併发症包括骨整合，即骨头在植体周围生长，并且可能会自行脱落。植牙的一项主要风险是鼻窦损伤，即上颚位于鼻窦正下方。用于替换上牙的植体可能会渗入鼻窦，导致不适或可能的感染。其他植入物也存在类似情况，因此预计这些情况将阻碍市场成长。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按产品分类的片段
  • 按材料类型分類的片段
  • 最终用户摘录
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 增加医疗植体的产品发布
      • 优惠报销政策
    • 限制
      • 与植牙相关的併发症
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情况
    • COVID-19 后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商的策略倡议
  • 结论

第 7 章：副产品

  • 骨科植入物
    • 髋关节植入物
    • 关节置换植入物
    • 脊椎植入物
    • 其他的
  • 心血管植入物
    • 起搏器
    • 植入式心臟復律去颤器 (ICD)
    • 心循环记录仪
  • 眼科植入物
    • 三焦点镜片
    • 扩展焦深 (EDOF) 水晶体植入
    • 单焦点晶状体植入
  • 植牙
    • 骨内膜
    • 骨膜下
  • 美容植入物
    • 脸部植入物
    • 乳房植入物

第 8 章：依材料类型

  • 陶瓷製品
  • 金属色
  • 聚合物
  • 其他的

第 9 章：最终用户

  • 医院
  • 骨科中心
  • ASC
  • 心臟中心
  • 脸部美容中心
  • 牙科医院
  • 其他的

第 10 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 产品基准化分析
  • 公司股份分析
  • 主要进展和策略

第 12 章：公司简介

  • Orthopedic Implant Company
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Auxein Medical
  • Medtronic Plc.
  • Stryker Corporation
  • 4Web Medical
  • Smith & Nephew
  • Novel Biocare Services AG
  • Strauman AG
  • GS Medical
  • CurvaFix Inc.

第 13 章：附录

简介目录
Product Code: MD1907

Overview

Medical implants are placed inside or on the surface of the body to replace a missing biological structure, support a damaged biological structure, and enhance an existing biological structure. Other medical implants help in delivering medication, monitor body functions, and provide support to organs and tissues.

Medical implants can either be placed permanently or temporarily. For example, stents or hip implants are intended to be permanent but chemotherapy ports or screws to repair broken bones can be removed when they are no longer needed. The surface of implants is made of a biomedical material such as titanium, silicone, or apatite.

Furthermore, significant growth drivers such as increasing technological advancements, product launches, and favorable reimbursement policies give rise to future market growth. Significant key players like Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, and others are actively operating in the market.

Dynamics

Increasing Product Launches for Medical Implants

Medical implants are used as prosthetics which are intended to replace missing body parts. The product launches by major companies help to drive market growth and these effective product launches help to transform research discoveries into new treatments and improve care for millions of people.

For instance, in February 2023, OSSIO, Inc. launched the new OSSIOfiber Compression Staple. OSSIOfiber Compression Staples are made with OSSIOfiber Intelligent Bone Regeneration Technology. OSSIOfiber provides the first credible solution to the shortcomings of permanent metal hardware and conventional resorbable and allograft implants by combining unparalleled mechanical strength and natural bone healing in a non-permanent implant.

Additionally, in December 2022, Abbott Laboratories launched its latest-generation transcatheter aortic valve implantation (TAVI) system called Navitor by making the minimally invasive device available for people with severe aortic stenosis who are at high or extreme surgical risk. Hence, due to the above factors, the market is expected to boost over the forecast period.

Favorable Reimbursement Policies are Boosting the Medical Implants Market

Reimbursement policies often consider factors such as the complexity of the procedure, the type of implant used, and the associated healthcare resources utilized during the procedure. Reimbursement policies play a crucial role in the medical implant market as they determine the level of coverage and financial reimbursement provided to healthcare providers for performing implantation procedures.

For instance, in March 2023, Inspire Medical Systems, Inc. stated that it has received countrywide reimbursement approval in Belgium, effective at rates consistent with other countries around the world. This reimbursement approval provides a pathway to open additional Inspire implanting centers in Belgium, under the guidance of Antwerp University Hospital (UZA) while also expanding access to care.

Additionally, in November 2022, Establishment Labs Holdings Inc. declared that Motiva Implants and the Motiva Flora tissue expander have been approved for use in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA), and these products have also received reimbursement for post-mastectomy reconstruction under the Japanese National Health System.

Complications Associated with Dental Implants Will Hamper the Growth of the Market

Complications of dental implants include osseointegration where the bone grows around your implant and it can fall out on its own. One major dental implant risk is sinus damage where the upper jaw is directly under the nasal sinuses. Implants that are used to replace the top teeth can potentially penetrate into the sinus which leads to discomfort or possible infection. There are similar instances with other implants and thus these are expected to hamper the market growth.

Segment Analysis

The global medical implants market is segmented based on product, material type, end users, and region.

Orthopedic Implants is expected to hold the largest market share over the period forecast owing to increasing product launches. An orthopedic implant is a manufactured device designed to replace a joint, bone, or cartilage due to damage or deformity such as from breaking a leg, losing a limb, or a congenital defect.

For instance, in February 2023, CurvaFix, Inc. launched its smaller-diameter, 7.5mm CurvaFix IM Implant which is designed to simplify surgery and provide strong, stable fixation in small-boned patients. The company showcases the new 7.5mm intramedullary device, of which over two dozen have already been implanted in patients, at the American Academy of Orthopedic Surgeons (AAOS) 2023 Annual Meeting.

Additionally, in July 2023, The Orthopaedic Implant Company commercially launched of its innovative Threaded Metacarpal Nail System. The Threaded Metacarpal Nail System features a low insertion torque and minimally compressive design, ensuring optimal stability for various fracture patterns.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

The global medical implants market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa. North America has maintained a significant proportion of the medical implants market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as the rising incidence of knee and hip replacements, and product launches in medical implants.

For instance, The American Joint Replacement Registry (AJRR), published its 2022 Annual Report on hip and knee arthroplasty procedural trends and patient outcomes. The annual report demonstrates an overall cumulative procedural volume growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, ambulatory surgery centers (ASCs), and private practice groups. The number of procedures submitted by ASCs has grown exponentially between 2012 and 2020 and has increased by 57%.

Additionally, according to the Aesthetic Society, there were 365,000 breast implantations performed in 2021. In addition, 148,000 women had implants removed and replaced, and 71,000 had their implants removed and not replaced in the United States. Hence, the above factors help accelerate the region's growth.

Competitive Landscape

The major global players in the market include: Orthopedic Implant Company, Auxein Medical, Medtronic Plc., Stryker Corporation, 4Web Medical, Smith & Nephew, Novel Biocare Services AG, Strauman AG, GS Medical, CurvaFix Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical implants market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular check-ups, appointments, device implantations, and consultations worldwide. Many hospitals are focused on COVID-19 cases, and this reduced cardiac surgery in many patients suffering from chronic disease.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical implants market is expected to be moderately affected over the forecast period.

By Product

  • Orthopedic Implant
    • Hip Implants
    • Joint Replacement Implant
    • Spine Implant
    • Others
  • Cardiovascular Implants
    • Pacemakers
    • Implantable Cardioverter Defibrillator (ICD)
    • Cardiac Loop Recorders
  • Ophthalmic Implants
    • Trifocal lens
    • Extended-depth-of-focus (EDOF) lens implant
    • Monofocal lens implant
  • Dental Implants
    • Endosteal
    • Subperiosteal
  • Cosmetic Implants
    • Facial Implants
    • Breast Implants

By Material Type

  • Ceramic
  • Metallic
    • Titanium
    • Cobalt
    • Tantalum
    • Nickel
    • Others
  • Polymers
  • Others

By End Users

  • Hospitals
  • Orthopedic Centers
  • ASCs
  • Cardiac Centers
  • Facial Aesthetics Centers
  • Dental Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In December 2022, Abbott Laboratories received the U.S. Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system which is the smallest implantable, rechargeable spinal cord stimulator.
  • In Aug 2023, 4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology launched the newest addition to the company's implant portfolio, the Cervical Spine Plating Solution (CSTS-PS).
  • In June 2023, Medics invested £1.8 million for clinical trials with the aim of precisely targeting heart patients who need tiny defibrillators to be fitted under their skin with the aim of reducing deaths from sudden cardiac arrests.

Why Purchase the Report?

  • To visualize the global medical implants market segmentation based on product, material type, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global medical implants market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical implants market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Product Launches for Medical Implants
      • 4.1.1.2. Favorable Reimbursement Policies
    • 4.1.2. Restraints
      • 4.1.2.1. Complications Associated with Dental Implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Orthopedic Implant
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Hip Implants
    • 7.2.4. Joint Replacement Implant
    • 7.2.5. Spine Implant
    • 7.2.6. Others
  • 7.3. Cardiovascular Implants
    • 7.3.1. Pacemakers
    • 7.3.2. Implantable Cardioverter Defibrillator (ICD)
    • 7.3.3. Cardiac Loop Recorders
  • 7.4. Ophthalmic Implants
    • 7.4.1. Trifocal lens
    • 7.4.2. Extended-depth-of-focus (EDOF) lens implant
    • 7.4.3. Monofocal lens implant
  • 7.5. Dental Implants
    • 7.5.1. Endosteal
    • 7.5.2. Subperiosteal
  • 7.6. Cosmetic Implants
    • 7.6.1. Facial Implants
    • 7.6.2. Breast Implants

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Ceramic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Metallic
  • 8.4. Polymers
  • 8.5. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopedic Centers
  • 9.4. ASCs
  • 9.5. Cardiac Centers
  • 9.6. Facial Aesthetics Centers
  • 9.7. Dental Hospitals
  • 9.8. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Orthopedic Implant Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Auxein Medical
  • 12.3. Medtronic Plc.
  • 12.4. Stryker Corporation
  • 12.5. 4Web Medical
  • 12.6. Smith & Nephew
  • 12.7. Novel Biocare Services AG
  • 12.8. Strauman AG
  • 12.9. GS Medical
  • 12.10. CurvaFix Inc.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us